Background illustration for clinical trials search

Paid Clinical Trials Nevada

Discover 491 paid clinical trials in Nevada. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter
1
Active & Responsive

A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease

for
Crohn's Disease
Location: London, Halifax, Providence RI, New York NY, Montreal,
Sponsor: Takeda

Sex: All

Age: 18 - 70+

Code: NCT06233461

Phase 2, Recruiting
Active & Responsive

Prevalence of Antibodies and Cytokines in Participants With Chronic Granulomatous Disease

for
Chronic Granulomatous Disease (CGD)
Location: Augusta ME, Boston MA, Providence RI, Concord NH,
Sponsor: Ensoma

Sex: All

Age: 0+

Code: NCT06605378

Recruiting
Active & Responsive

A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)

for
Prostate Cancer, Prostatic Neoplasms
Location: Boston MA, New Haven CT, West Haven CT, New York NY,
Sponsor: Merck Sharp & Dohme LLC

Sex: Male

Age: 18+

Code: NCT06925737

Phase 3, Recruiting
Active & Responsive

Safety and Efficacy Study of ICXP007 With Compression Bandaging for the Treatment of Non-Infected Venous Leg Ulcers

for
Leg Ulcer
Location: Boston MA, Providence RI, Chapel Hill NC, Tamarac FL,
Sponsor: Intercytex

Sex: All

Age: 18+

Code: NCT00232973

Phase 3, Recruiting

Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies

for
Hematopoietic Cell Transplantation Recipient, Leukemia,
Location: Boston MA, Providence RI, Hartford CT, New Haven CT,
Sponsor: Children's Oncology Group

Sex: All

Age: 0+

Code: NCT00736749

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
New

T-DXd Based Therapy Followed by Endocrine Therapy Plus Dual HER2 Blockade in First-line HER2+/ HR+ Metastatic Breast Cancer and Retreatment With T-DXd

for
Advanced Breast Cancer, Metastatic Breast Cancer, HER2 Positive,
Location: Columbia MD, Nashville TN, New Braunfels TX, El Paso TX,
Sponsor: Daiichi Sankyo

Sex: All

Age: 18+

Code: NCT07683754

Phase 3, Recruiting
New

Application of the Patient-reported Longitudinal Assessment Tool for OSA (PLATO) Questionnaire in Oral Appliance Therapy for Obstructive Sleep Apnea

for
Obstructive Sleep Apnea (OSA), Oral Applliance Therapy
Location: Henderson NV
Sponsor: Nevada Dental Sleep

Sex: All

Age: 18+

Code: NCT07789834

Recruiting
New

Symbiotic-GYN-18: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Advanced or Recurrent MMR-proficient Endometrial Cancer

for
Endometrial Neoplasms, Endometrial Cancer
Location: White Plains NY, Norfolk VA, Chesapeake VA, Suffolk VA,
Sponsor: Pfizer

Sex: Female

Age: 18+

Code: NCT07578649

Phase 3, Recruiting
New

A Phase 3 Trial for Intravitreal Injection of 4D-150 in Adults With Diabetic Macular Edema (DME).

for
Diabetic Macular Edema (DME)
Location: Greenwich CT, Bloomfield NJ, New York NY, Fairfax VA,
Sponsor: 4D Molecular Therapeutics

Sex: All

Age: 18+

Code: NCT07867080

Phase 3, Recruiting

Letrozole in Uterine Leiomyosarcoma

for
Uterine Leiomyosarcoma
Location: Providence RI, Worcester MA, Summit NJ, Morristown NJ,
Sponsor: GOG Foundation

Sex: Female

Age: 18+

Code: NCT05649956

Phase 2, Recruiting

Neoadjuvant Chemotherapy, Excision And Observation vs Chemoradiotherapy For Rectal Cancer

for
Rectal Cancer
Location: St. John's, Gloucester MA, Beverly MA, Burlington MA,
Sponsor: Canadian Cancer Trials Group

Sex: All

Age: 18+

Code: NCT06205485

Phase 3, Recruiting

A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer

for
Hormone Receptor Positive HER-2 Negative Breast Cancer,
Location: Boston MA, Horsham PA, Philadelphia PA, Richmond VA,
Sponsor: Puma Biotechnology, Inc.

Sex: All

Age: 18+

Code: NCT06369285

Phase 2, Recruiting

A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions

for
Myelodysplastic Syndromes
Location: Halifax, New Haven CT, Westbury NY, Columbia MD,
Sponsor: Takeda

Sex: All

Age: 18+

Code: NCT06499285

Phase 3, Recruiting

Parkinson's Foundation PD GENEration Genetic Registry

for
Parkinson's Disease
Location: Boston MA, Farmington CT, New York NY, Philadelphia PA,
Sponsor: Parkinson's Foundation

Sex: All

Age: 18+

Code: NCT04994015

Recruiting

52 Week Study + 24-Month Long-Term Extension of Safety, PK, & Efficacy of XYOSTED® for Testosterone Replacement in Male Adolescents With Hypogonadism

for
Hypogonadism, Male
Location: Boston MA, Worcester MA, The Bronx NY, Philadelphia PA,
Sponsor: Halozyme Therapeutics

Sex: Male

Age: 12 - 17

Code: NCT06689085

Phase 3, Recruiting

A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treatment for HER2-positive Gastric Cancer

for
HER2-positive Gastric Cancer,
Location: Chicoutimi, New York NY, Albany NY, Summit NJ, Montreal,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06764875

Phase 3, Recruiting

AN INTERNATIONAL, OBSERVATIONAL, BLINDED STUDY TO ASSESS THE PERFORMANCE OF THE CORDIO HEARO SYSTEM

for
Heart Failure
Location: Roslyn NY, New York NY, Miami FL, Plantation FL,
Sponsor: Cordio Medical

Sex: All

Age: 22+

Code: NCT06378632

Recruiting

Concurrent Ipilimumab and Stereotactic Ablative Radiation Therapy (SART) for Oligometastatic But Unresectable Melanoma

for
Melanoma
Location: Las Vegas NV
Sponsor: Wolfram Samlowski

Sex: All

Age: 18+

Code: NCT01565837

Phase 2, Recruiting

TEMPUS ARIES: A Biobank Registry Platform Study in Oncology

for
Cancer
Location: Fairhaven MA, Norwich CT, York PA, East Syracuse NY,
Sponsor: Tempus AI

Sex: All

Age: 18 - 70+

Code: NCT06207032

Recruiting

A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)

for
Non Small Cell Lung Cancer
Location: Westbrook ME, Stony Brook NY, Stamford CT,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06312137

Phase 3, Recruiting

Popular cities in Nevada

HendersonLas VegasReno